HomeNewsTrendsHealthIndia reports 1,685 new COVId-19 cases, 83 deaths in a day

India reports 1,685 new COVId-19 cases, 83 deaths in a day

Nine states and UTs have reported a meagre rise in active infections over the last 24 hours

March 25, 2022 / 09:24 IST
Story continues below Advertisement
Representative image
Representative image

India reported 1,685 new COVID-19 cases in the last 24 hours continuing with its trend of clocking less than 2,000 daily cases for the last six days.

The fresh number of infections takes the tally of confirmed coronavirus cases in the country to 4,30,16,372.

Story continues below Advertisement

The number of active cases has now come down to 21,530 - down 897 from the previous day - and the active cases now constitute 0.05 percent of the total confirmed cases.

Also read I Health ministry urges states to keep a vigil on COVID-19 patterns at district level as restrictions end on March 31

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show